An Oxford University trial of a coronavirus vaccine has been put on hold due to safety concerns after a trial participant had a serious adverse reaction, in what AstraZeneca referred to as a "routine action".
Trials of an Oxford University coronavirus vaccine have been put on hold after a participant experienced a serious adverse reaction.
Australia has ordered 33 million doses of the AstraZeneca vaccine to be rolled out from early next year if the trials prove successful.
Read the full article in English here.
Share
